intrauterine adhesion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women aged 20 to 40 (including 20 and 40); 2. BMI < 30 kg/m2; 3. The patient was diagnosed with uterine cavity adhesion by hysteroscopy, and the uterine cavity adhesion score was in line with the American Fertility Society (AFS) grade II (score 5-8 points); 4. The patient voluntarily participated in the clinical trial and signed the Informed Consent.
Exclusion criteria
Exclusion criteria: 1. Patients with genital tract infection; 2. Patients with malignant tumors; Patients with complex hyperplasia of endometrium and atypical hyperplasia; 3. Patients with intramural myoma or adenomyosis of the uterus, whose uterus is larger than 60 days of pregnancy, and accompanied by excessive menstruation; Submucosal myoma of uterus; 4. Patients with abnormal coagulation function, or serious heart, liver, lung, kidney and other important organ diseases, serious systemic diseases, immune insufficiency, and poor control of diabetes and hypertension; 5. Patients with severe allergic symptoms, especially those with collagen allergy; 6. Patients who have participated or are participating in clinical trials of other drugs or devices in the past 3 months; 7. Other patients who were determined by the researcher to be unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of preventing adhesion recurrence ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative American Fertility Society (AFS) score and changes;Postoperative menstrual blood volume and changes; | — |
Countries
China
Contacts
Gulou Hospital affiliated to Nanjing University Medical College